Work

Editorial: Molecular Network Study of Pituitary Adenomas

Year: 2020

Type: editorial

Abstract: network system (4,5,10,11). Molecular network alterations are the hallmark, and play central roles in pituitary pathogenesis (12,13). A key molecule-panel biomarker that is derived from molecular network is necessary for accurately clinical practice of a pituitary adenoma (13). The modern multi-omics, computation biology, and systems biology technologies lead to the possibility in recognizing really reliable molecular-panel biomarker for research and clinical practice in pituitary adenomas.This present issue mainly focuses on the molecular network study of pituitary adenomas, which contains fourteen topics: (i) The first topic addressed that a tyrosine kinase inhibitor imatinib inhibited growth hormone (GH) secretion signaling via PDGFR-β pathway, but did not affect cell viability and apoptosis, which might be used as an adjunct therapy to treat

Source: Frontiers in Endocrinology

DOI: 10.3389/fendo.2020.00026

Authors: Xianquan Zhan, Dominic M. Desiderio

Institutions: Central South University, Xiangya Hospital Central South University, Shandong First Medical University, University of Tennessee Health Science Center

Language: English

Topic: Pituitary Gland Disorders and Treatments

Subfield: Endocrinology, Diabetes and Metabolism

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $2,950